Stock profile

INTUITIVE SURGICAL INC (ISRG)

ISRG · Latest close $438.00 as of Oct 20, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$438.00
As of Oct 20, 2026
Tracked funds holding
16 of 149
2026 Q2 13F filings
Opened / added
2 / 4
vs previous quarter
Trimmed / exited
13
vs previous quarter

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
Edgewood Management4.28%1,042,949TRIMMED (-33.0%)
Bristol (John W. Bristol & Co.)2.27%386,569ADDED (+7.2%)
Alphinity Investment Management2.22%334,585TRIMMED (-39.8%)
Mirova US2.11%492,324TRIMMED (-3.9%)
Sands Capital Management1.85%1,252,424TRIMMED (-5.2%)
Polen Capital Management1.53%447,944TRIMMED (-26.2%)
OrbiMed Advisors1.16%157,900TRIMMED (-24.3%)
Sarasin & Partners1.14%244,426ADDED (+128.2%)
Disciplined Growth Investors0.71%106,000TRIMMED (-0.9%)
D1 Capital Partners0.66%574,200NEW
Coatue Management0.65%793,704TRIMMED (-7.2%)
GQG Partners0.58%780,428NEW
Mairs & Power Funds0.53%146,459ADDED (+46.6%)
Perceptive Advisors0.31%51,884TRIMMED (-39.3%)
Winslow Capital Management0.01%7,450TRIMMED (-99.4%)
Saturna Capital0.01%2,018ADDED (+162.8%)

Source: SEC Form 13F filings for the quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. 13F filings cover long positions only and arrive up to 45 days after quarter-end. Fund counts here aggregate every share class mapped to this ticker; research headlines cite filer counts as they stood at publication, so a count here can differ from a headline by a holder (see Methodology, "How holder counts are counted").

Exited this quarter: Dodge & Cox Funds, RTW Investments, Axiom Investors.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

All institutions · Form 13F

Institutions holding2,233 of 8,857 filers
Long-only filers among them2,228
Change vs 2026 Q1-22 net · 1,646 entered · 1,668 exited
Shares reported, all filers302,442,187
Reported value, all filers$117.4B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNasdaq
IndustryOrthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Revenue · FY2025$10.1B
Net income · FY2025$2.9B
Total assets · FY2025$20.5B
Shares outstanding353,278,038
Market cap (at latest close)$154.7B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 7, 2026. Shares outstanding as reported Jul 16, 2026.

Short interest

Shares short · Sep 15, 20268,117,017
Share of shares outstanding2.30%
Days to cover3.35

Shares short at recent settlements — Jun 30, 2026: 7.3M · Jul 15, 2026: 6.7M · Jul 31, 2026: 6.6M · Aug 14, 2026: 7.1M · Aug 31, 2026: 7.7M · Sep 15, 2026: 8.1M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Jul 16, 2026.

Fails to deliver

Shares failed to deliver · Sep 15, 20260
Share of shares outstanding0.00%
Fails as a share of short interest · Sep 15, 20260.0%

Fails to deliver at recent settlements — Jun 30, 2026: 0 · Jul 15, 2026: 0 · Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 0 · Sep 15, 2026: 0.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Jul 16, 2026.

Insider trading · Form 4

0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 20 sales by 5 insiders ($5.0M).

Source: SEC Form 4 filings, as of Oct 21, 2026. Open-market transactions only.

Politician trading · U.S. Congress

Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Oct 3, 2026).

Screens & lenses

Financial Screens

· Growth — Revenue up every year for 5 straight years

· Graham — Sound finances and a long run of profits

· Earnings Quality (Cash Conversion) — Profits that actually come back as cash

· Earnings Stability — Small earnings swings and almost no loss years

Key figures

· Growth — Latest revenue: $10.1B · 5-yr revenue CAGR: 18.2% · Straight growth years: 5

· Graham — Current ratio: 4.87 · Straight profitable years: 19 · Debt ratio: 0.14 · Latest net income: $2.9B

· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 1.04 · Operating cash flow: $3.0B · Net income: $2.9B

· Earnings Stability — Earnings variation (CV): 0.44 · Loss years (of 10): 0 · Latest net income: $2.9B

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Signal record

· Politician BEST — appeared in 4 of the last 20 quarterly lists; latest 2024 Q2, ranked #14 of 50.

13F signal (2021 Q3 – 2026 Q1)EventsWin rateAvg returnSPYExcess
Heavy accumulation — 3+ tracked funds increased together20.0%-21.0%-6.4%-14.6%

Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.

Related stocks

Also held by the tracked funds that hold ISRG: AMAZON COM INC (AMZN) · Meta Platforms, Inc. (META) · NVIDIA CORP (NVDA) · MICROSOFT CORP (MSFT) · Apple Inc. (AAPL) · Broadcom Inc. (AVGO) · Alphabet Inc. (GOOGL) · TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD (TSM) · VISA INC. (V) · ELI LILLY & Co (LLY).

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.